5/16
03:15 am
bcli
Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
5/14
04:40 pm
bcli
BrainStorm Cell Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update [Yahoo! Finance]
Medium
Report
BrainStorm Cell Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update [Yahoo! Finance]
5/14
04:30 pm
bcli
BrainStorm Cell Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update
Medium
Report
BrainStorm Cell Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update
5/9
12:33 am
bcli
Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
4/16
06:35 pm
bcli
BrainStorm Cell Therapeutics Announces Management Changes as Company Plans Registrational Phase 3b Trial of NurOwn [Yahoo! Finance]
Medium
Report
BrainStorm Cell Therapeutics Announces Management Changes as Company Plans Registrational Phase 3b Trial of NurOwn [Yahoo! Finance]
4/16
06:30 pm
bcli
BrainStorm Cell Therapeutics Announces Management Changes as Company Plans Registrational Phase 3b Trial of NurOwn
Low
Report
BrainStorm Cell Therapeutics Announces Management Changes as Company Plans Registrational Phase 3b Trial of NurOwn
4/11
06:09 am
bcli
BrainStorm Cell Therapeutics Regains Compliance with NASDAQ Minimum Market Value Rule [Yahoo! Finance]
Medium
Report
BrainStorm Cell Therapeutics Regains Compliance with NASDAQ Minimum Market Value Rule [Yahoo! Finance]
4/11
06:00 am
bcli
BrainStorm Cell Therapeutics Regains Compliance with NASDAQ Minimum Market Value Rule
Medium
Report
BrainStorm Cell Therapeutics Regains Compliance with NASDAQ Minimum Market Value Rule
11/14/2023
07:05 am
BCLI
brainstorm cell therapeutics inc.
BEAT
Report
-0.9%
brainstorm cell therapeutics inc.
8/14/2023
07:05 am
BCLI
brainstorm cell therapeutics inc.
BEAT
Report
3.7%
brainstorm cell therapeutics inc.
5/14
05:01 pm
bcli
Form 10-Q BRAINSTORM CELL THERAPEU For: Mar 31
Medium
Report
Form 10-Q BRAINSTORM CELL THERAPEU For: Mar 31
5/14
07:53 am
bcli
Form 4 BRAINSTORM CELL THERAPEU For: May 10 Filed by: Lebovits Chaim
Medium
Report
Form 4 BRAINSTORM CELL THERAPEU For: May 10 Filed by: Lebovits Chaim
5/7
07:42 pm
bcli
Form 4 BRAINSTORM CELL THERAPEU For: May 07 Filed by: Lebovits Chaim
High
Report
Form 4 BRAINSTORM CELL THERAPEU For: May 07 Filed by: Lebovits Chaim
5/7
09:14 am
bcli
Form 4 BRAINSTORM CELL THERAPEU For: May 06 Filed by: Lebovits Chaim
Low
Report
Form 4 BRAINSTORM CELL THERAPEU For: May 06 Filed by: Lebovits Chaim
5/3
04:07 pm
bcli
Form 8-K BRAINSTORM CELL THERAPEU For: May 01
Low
Report
Form 8-K BRAINSTORM CELL THERAPEU For: May 01
4/25
04:02 pm
bcli
Form 4 BRAINSTORM CELL THERAPEU For: Apr 19 Filed by: Lebovits Chaim
Low
Report
Form 4 BRAINSTORM CELL THERAPEU For: Apr 19 Filed by: Lebovits Chaim
4/22
08:07 pm
bcli
Form 3 BRAINSTORM CELL THERAPEU For: Apr 17 Filed by: Dagher Ibrahim B.
Medium
Report
Form 3 BRAINSTORM CELL THERAPEU For: Apr 17 Filed by: Dagher Ibrahim B.
4/19
06:06 am
bcli
Form 4 BRAINSTORM CELL THERAPEU For: Apr 17 Filed by: Lebovits Chaim
Low
Report
Form 4 BRAINSTORM CELL THERAPEU For: Apr 17 Filed by: Lebovits Chaim
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register